• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳头瘤病毒检测的质量评估

Quality assessment for human papillomavirus testing.

作者信息

Tabrizi Sepehr N

机构信息

Department of Microbiology and Infectious Diseases, The Royal Women's Hospital, Parkville, Australia.

出版信息

Sex Health. 2010 Sep;7(3):335-7. doi: 10.1071/SH09152.

DOI:10.1071/SH09152
PMID:20719224
Abstract

There are over 30 commercial, as well as numerous in-house assays, available for human papillomavirus testing. Laboratories performing such assays would need to assess accuracy and reproducibility of their results by incorporating ongoing internal control as well as participating in external quality-assurance schemes (EQAS) as part of their quality assurance program. Several EQAS are available and participation in which is a requirement for laboratories engaged in HPV testing. It is important that laboratories select the appropriate panels for detection of targeted types covered by assay used. Failure to do so can possibly alter patient management and increase the cost of treatment.

摘要

有超过30种商业检测方法以及众多内部检测方法可用于人乳头瘤病毒检测。进行此类检测的实验室需要通过纳入持续的内部控制以及参与外部质量保证计划(EQAS)来评估其结果的准确性和可重复性,这是其质量保证计划的一部分。有几种EQAS可供使用,参与其中是从事HPV检测的实验室的一项要求。重要的是,实验室要选择合适的检测组来检测所用检测方法涵盖的目标类型。否则可能会改变患者的治疗管理并增加治疗成本。

相似文献

1
Quality assessment for human papillomavirus testing.人乳头瘤病毒检测的质量评估
Sex Health. 2010 Sep;7(3):335-7. doi: 10.1071/SH09152.
2
Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era.人乳头瘤病毒疫苗接种后时代宫颈癌筛查的前景策略。
Sex Health. 2010 Sep;7(3):376-82. doi: 10.1071/SH10022.
3
A peer comparison program for the quality assurance of human papillomavirus DNA detection using the Digene Hybrid Capture II/SurePath method shows excellent analytic interlaboratory correlation.一项使用Digene Hybrid Capture II/SurePath方法对人乳头瘤病毒DNA检测进行质量保证的同行比较计划显示出出色的实验室间分析相关性。
Cancer. 2007 Oct 25;111(5):339-43. doi: 10.1002/cncr.22951.
4
Human papillomavirus testing for primary screening of cervical cancer precursors.人乳头瘤病毒检测用于宫颈癌前病变的初筛
Cancer Epidemiol Biomarkers Prev. 2000 Sep;9(9):945-51.
5
HPV testing for cervical cancer screening in Croatia.克罗地亚用于宫颈癌筛查的人乳头瘤病毒检测
Coll Antropol. 2007 Apr;31 Suppl 2:67-71.
6
[HPV test for quality control of gynecologic cytological tests].[用于妇科细胞学检查质量控制的人乳头瘤病毒检测]
Lakartidningen. 2008;105(48-49):3560, 3564.
7
Australian women's needs and preferences for information about human papillomavirus in cervical screening.澳大利亚女性对于子宫颈癌筛查中人类乳头瘤病毒信息的需求及偏好。
J Med Screen. 2005;12(3):134-41. doi: 10.1258/0969141054855238.
8
Periodic health examination, 1995 update: 1. Screening for human papillomavirus infection in asymptomatic women. Canadian Task Force on the Periodic Health Examination.定期健康检查,1995年更新版:1. 无症状女性人乳头瘤病毒感染筛查。加拿大定期健康检查特别工作组。
CMAJ. 1995 Feb 15;152(4):483-93.
9
Cervical cancer screening in the 21st century: is it time to retire the PAP smear?21世纪的宫颈癌筛查:是时候淘汰巴氏涂片检查了吗?
Clin Obstet Gynecol. 2007 Jun;50(2):313-23. doi: 10.1097/GRF.0b013e31804a8285.
10
HPV DNA testing of the residual sample of liquid-based Pap test: utility as a quality assurance monitor.液基薄层涂片检查剩余样本的人乳头瘤病毒DNA检测:作为质量保证监测手段的效用
Mod Pathol. 2001 Mar;14(3):147-51. doi: 10.1038/modpathol.3880271.

引用本文的文献

1
Comparison of PapType to Digene Hybrid Capture 2, Roche linear array, and Amplicor for detection of high-risk human papillomavirus genotypes in women with previous abnormal pap smears.比较 PapType 与 Digene Hybrid Capture 2、罗氏线性阵列和 Amplicor 检测既往巴氏涂片异常女性的高危型人乳头瘤病毒基因型。
J Clin Microbiol. 2012 Aug;50(8):2796-8. doi: 10.1128/JCM.01064-12. Epub 2012 May 30.